# Aura Biosciences, Inc. (AURA): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/aura for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Biotechnology
- Exchange: NASDAQ · Trading currency: USD

Headquartered in Cambridge, Massachusetts, Aura Biosciences, Inc. is a biotechnology firm established in 2009 that specializes in pioneering cancer treatments. The company leverages its proprietary virus-like drug conjugate (VDC) technology platform to address tumors with significant unmet medical needs, specifically in ocular (eye) and urologic oncology. Its flagship therapeutic candidate, AU-011, is a VDC currently in development for the treatment of primary choroidal melanoma. Furthermore, Aura Biosciences is investigating AU-011's potential for other ocular oncology applications, such a...

## Quote & Key Metrics

As of 2026-10-23:

| Metric | Value |
|---|---|
| Price | $6.30 USD |
| Market Cap | $653.3M |
| P/E (TTM) | — |
| EPS (TTM) | −$1.75 |
| 52-Week Range | $4.73 – $9.54 |
| Dividend Yield (TTM) | — |

## Dividend

AURA has no dividend payment history in our records.

## Frequently Asked Questions

### What does Aura Biosciences, Inc. do?

Aura Biosciences, Inc. (AURA) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is AURA's market cap?

Aura Biosciences, Inc. (AURA) has a market capitalization of approximately $653.3 million, as of October 23, 2026, based on the most recent share price and shares outstanding.

### Does AURA pay a dividend?

No, Aura Biosciences, Inc. (AURA) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

### Is AURA profitable?

Aura Biosciences, Inc. (AURA) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

### Has AURA ever paid a dividend?

No. Dividend Data's records show no dividend payments from Aura Biosciences, Inc. (AURA). A first dividend would appear on the Dividend tab once it is declared.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/aura
- Dividend history & safety: https://www.dividenddata.com/stocks/aura/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/aura/earnings
- Financial statements: https://www.dividenddata.com/stocks/aura/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/aura/valuation
- Peer comparison: https://www.dividenddata.com/stocks/aura/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.